This means that Filgrastim ratiopharm is similar to a biological medicine that is already authorised in the European Union (EU) and contains the same active substance (also known as the ‘ reference medicine’).
See tähendab, et Filgrastim ratiopharm on sarnane bioloogilise ravimiga, millel on juba Euroopa Liidus müügiluba ning mis sisaldab sama toimeainet (nimetatakse ka võrdlusravimiks).